177 related articles for article (PubMed ID: 34272229)
1. Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine.
Cancer Discov; 2021 Sep; 11(9):2122. PubMed ID: 34272229
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccination: the VOICE for patients with cancer.
van der Veldt AAM; Oosting SF; Dingemans AC; Fehrmann RSN; GeurtsvanKessel C; Jalving M; Rimmelzwaan GF; Kvistborg P; Blank CU; Smit EF; Lemmens VEEP; Hiltermann TJN; Koopmans MPG; Huckriede ALW; Rots NY; van Els CACM; van Baarle D; Haanen JBAG; de Vries EGE
Nat Med; 2021 Apr; 27(4):568-569. PubMed ID: 33589821
[No Abstract] [Full Text] [Related]
4. On reaching herd immunity during the COVID-19 pandemic and further issues.
Pandolfi S; Chirumbolo S
J Med Virol; 2022 Jan; 94(1):24-25. PubMed ID: 34491592
[No Abstract] [Full Text] [Related]
5. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience.
Yigit M; Ozkaya-Parlakay A; Cosgun Y; Ince YE; Bulut YE; Senel E
J Med Virol; 2022 Jan; 94(1):287-290. PubMed ID: 34487373
[TBL] [Abstract][Full Text] [Related]
6. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Krammer F; Srivastava K; Alshammary H; Amoako AA; Awawda MH; Beach KF; Bermúdez-González MC; Bielak DA; Carreño JM; Chernet RL; Eaker LQ; Ferreri ED; Floda DL; Gleason CR; Hamburger JZ; Jiang K; Kleiner G; Jurczyszak D; Matthews JC; Mendez WA; Nabeel I; Mulder LCF; Raskin AJ; Russo KT; Salimbangon AT; Saksena M; Shin AS; Singh G; Sominsky LA; Stadlbauer D; Wajnberg A; Simon V
N Engl J Med; 2021 Apr; 384(14):1372-1374. PubMed ID: 33691060
[No Abstract] [Full Text] [Related]
7. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
Tran S; Truong TH; Narendran A
Eur J Cancer; 2021 Dec; 159():259-274. PubMed ID: 34798454
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
Alidjinou EK; Gaillot O; Guigon A; Tinez C; Lazrek M; Bocket L; Engelmann I; Hober D
Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115565. PubMed ID: 34731684
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer.
Shapiro LC; Thakkar A; Campbell ST; Forest SK; Pradhan K; Gonzalez-Lugo JD; Quinn R; Bhagat TD; Choudhary GS; McCort M; Sica RA; Goldfinger M; Goel S; Anampa JD; Levitz D; Fromowitz A; Shah AP; Sklow C; Alfieri G; Racine A; Wolgast L; Greenberger L; Verma A; Halmos B
Cancer Cell; 2022 Jan; 40(1):3-5. PubMed ID: 34838186
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
Abu Jabal K; Ben-Amram H; Beiruti K; Brimat I; Abu Saada A; Bathish Y; Sussan C; Zarka S; Edelstein M
Epidemiol Infect; 2021 Aug; 149():e239. PubMed ID: 34399868
[TBL] [Abstract][Full Text] [Related]
11. Seroconversion rates following COVID-19 vaccination among patients with cancer.
Thakkar A; Gonzalez-Lugo JD; Goradia N; Gali R; Shapiro LC; Pradhan K; Rahman S; Kim SY; Ko B; Sica RA; Kornblum N; Bachier-Rodriguez L; McCort M; Goel S; Perez-Soler R; Packer S; Sparano J; Gartrell B; Makower D; Goldstein YD; Wolgast L; Verma A; Halmos B
Cancer Cell; 2021 Aug; 39(8):1081-1090.e2. PubMed ID: 34133951
[TBL] [Abstract][Full Text] [Related]
12. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.
Boyarsky BJ; Chiang TP; Teles AT; Greenberg RS; Krach MR; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL; Werbel AWA
Transplantation; 2021 Oct; 105(10):e137-e138. PubMed ID: 34241987
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
[No Abstract] [Full Text] [Related]
14. Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
Slomski A
JAMA; 2021 Sep; 326(9):800. PubMed ID: 34547092
[No Abstract] [Full Text] [Related]
15. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Bradley T; Grundberg E; Selvarangan R; LeMaster C; Fraley E; Banerjee D; Belden B; Louiselle D; Nolte N; Biswell R; Pastinen T; Myers A; Schuster J
N Engl J Med; 2021 May; 384(20):1959-1961. PubMed ID: 33755375
[No Abstract] [Full Text] [Related]
16. Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19.
Chan L; Fuca N; Zeldis E; Campbell KN; Shaikh A
Clin J Am Soc Nephrol; 2021 Aug; 16(8):1258-1260. PubMed ID: 34031182
[No Abstract] [Full Text] [Related]
17. Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
Anand S; Montez-Rath ME; Han J; Garcia P; Cadden L; Hunsader P; Kerschmann R; Beyer P; Dittrich M; Block GA; Boyd SD; Parsonnet J; Chertow GM
J Am Soc Nephrol; 2021 Oct; 32(10):2435-2438. PubMed ID: 34117129
[No Abstract] [Full Text] [Related]
18. Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.
Joob B; Wiwanitkit V
Clin Appl Thromb Hemost; 2021; 27():10760296211020833. PubMed ID: 34142570
[No Abstract] [Full Text] [Related]
19. SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
Abbasi J
JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519816
[No Abstract] [Full Text] [Related]
20. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
